Ledger.Open graph →
SEC Form D · filed September 30, 2016

Roka BioScience, Inc

Offering
$22.5M
Sold
$22.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WARREN, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Perry M. Fischer · Seattle, WADirectorPaul G. Thomas · Warren, NJExec · DirectorLouis G. Fasulo · Seattle, WAExec · DirectorMichael P. Doyle · Mason, OHDirectorNicholas G. Valeriani · Warren, NJDirectorBrad Feld · Charlotte, NCDirectorFred G. Cohen · Warren, NJDirectorDeepak Sindwani · Boston, MADirectorLars Boesgaard · Warren, NJExecJonathan G. Silverstein · Warren, NJDirectorLars Boesgaard · Warren, NJExecNicholas G. Valeriani · Warren, NJDirectorDavid G. Mcgirr · Warren, NJDirectorJoel Wilhite · CHARLOTTE, NCDirectorColleen Taylor · CHARLOTTE, NCExec · DirectorNicolas Westphal · CHARLOTTE, NCDirectorDavid G. Mcgirr · Warren, NJDirectorJim Hausman · CHARLOTTE, NCDirectorTony M. Abena · Seattle, WADirectorJim G. Barret, Phd · Warren, NJDirectorVaibhav Nalwaya · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗